A late presentation of ocular quinine toxicity managed with a combination of vasodilatory treatments [2]

Eye

Volumn 19, Issue 7, 2005, Pages 801-802

  Vusirikala, B ^a   Williams, T A ^a   Ram, A R R ^a  

^a ROYAL GLAMORGAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIEMETIC AGENT; CLONIDINE; NIMODIPINE; QUININE SULFATE; ROPIVACAINE; VASODILATOR AGENT;

ADULT; AMBLYOPIA; CASE REPORT; COLOR VISION DEFECT; DRUG OVERDOSE; EYE TOXICITY; FEMALE; FLUID THERAPY; HUMAN; HYPOTENSION; LETTER; NAUSEA; SINUS TACHYCARDIA; STELLATE GANGLION BLOCK; VISUAL IMPAIRMENT;

EID: 22744448689     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701631     Document Type: Letter

References (5)

1. Boland ME. Complications of quinine poisoning. Lancet 1985; I: 384-385.
2. Moffat AC. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids and Post mortem Material, 2nd edn. Pharmaceutical press: London, 1986, pp. 954-955.
3. Jaeger A. Clinical features and management of poisoning due to antimalarial drugs. Med Toxicol 1987; 2: 242-273.
4. Moore D, Marshall J, Henry JA. Research into quinine ocular toxicity. Br J Ophthamol 1992; 76: 131-134.
5. Boscoe MJ, Calver DM, Keyte C. Quinine overdose: prevention of visual damage by stellate ganglion block. Anaesthesia 1983; 38: 669-671.